The weekly litigation news digest is live. Subscribe now

IP Verse

Ucb Biopharma Sprl competitive analysis

Loading summary...

Latest patents of Ucb Biopharma Sprl opposed by its competitors

Explore Ucb Biopharma Sprl's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3311168
May 10, 2023Novel Tnf Structure For Use In Therapy1
EP2515887
Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine2
EP2922533
Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2

Latest PTAB cases involving Ucb Biopharma Sprl

Discover the latest PTAB cases involving Ucb Biopharma Sprl, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ucb Biopharma Sprl with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UCB BIOPHARMA SPRL - 5 - -
AMW32 - -
DR H ULRICH DORRIES26 - - -
GENERICS UK214 - - -